BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12525747)

  • 1. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
    Louis E; Keime-Guibert F; Delattre JY; Sanson M
    Neurology; 2003 Jan; 60(1):151. PubMed ID: 12525747
    [No Abstract]   [Full Text] [Related]  

  • 2. Gliomatosis cerebri: better definition, better treatment.
    Chamberlain MC
    Neurology; 2004 Jul; 63(2):204-5. PubMed ID: 15277608
    [No Abstract]   [Full Text] [Related]  

  • 3. Gliomatosis cerebri.
    Kaplan SS; Park TS; McKinstry RC; Fuller C; Ojemann JG
    Pediatr Neurosurg; 2002 Feb; 36(2):111-2. PubMed ID: 11893895
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gliomatosis cerebri: report of 3 cases and review of recent literatures].
    Arai M; Kashihara K; Kaizaki Y; Taguchi M; Kitamura Y
    No To Shinkei; 2003 Oct; 55(10):890-7. PubMed ID: 14635518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial chemotherapy in gliomatosis cerebri.
    Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
    Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of the immediate efficacy of chemotherapy in a female patient with a glioblastoma].
    Kobiakov GL; Loshakov VA; Lichinitser MR
    Zh Vopr Neirokhir Im N N Burdenko; 1996; (4):39-41. PubMed ID: 9092255
    [No Abstract]   [Full Text] [Related]  

  • 7. Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri.
    Schiff D
    Neurology; 2003 Aug; 61(3):425; author reply 425. PubMed ID: 12913224
    [No Abstract]   [Full Text] [Related]  

  • 8. Gliomatosis cerebri treatment in 11 elderly patients.
    Piccirilli M; Landi A; Salvati M
    J Exp Clin Cancer Res; 2006 Jun; 25(2):183-7. PubMed ID: 16918128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
    Glas M; Bähr O; Felsberg J; Rasch K; Wiewrodt D; Schabet M; Simon M; Urbach H; Steinbach JP; Rieger J; Fimmers R; Bamberg M; Nägele T; Reifenberger G; Weller M; Herrlinger U;
    Ann Neurol; 2011 Sep; 70(3):445-53. PubMed ID: 21710625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procarbazine and CCNU as initial treatment in gliomatosis cerebri.
    Glas M; Rasch K; Wiewrodt D; Weller M; Herrlinger U
    Oncology; 2008; 75(3-4):182-5. PubMed ID: 18841032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant chemotherapy for gliomatosis cerebri.
    Kong DS; Kim ST; Lee JI; Suh YL; Lim DH; Kim WS; Kwon KH; Park K; Kim JH; Nam DH
    BMC Cancer; 2010 Aug; 10():424. PubMed ID: 20704759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma.
    Paleologos NA; Macdonald DR; Vick NA; Cairncross JG
    Neurology; 1999 Sep; 53(5):1141-3. PubMed ID: 10496285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Adolescent Presenting With Seizures as a Symptom of Gliomatosis Cerebri.
    Blanco-Iglesias E; Cabeza B; Esparza EG; de Prada I; Lassaletta A; Budke M; Serrano A
    Pediatr Emerg Care; 2018 Dec; 34(12):e229-e232. PubMed ID: 28486262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
    Benjelloun A; Delavelle J; Lazeyras F; Dietrich PY
    Neurology; 2001 Nov; 57(10):1932-3. PubMed ID: 11723300
    [No Abstract]   [Full Text] [Related]  

  • 15. Response and control: lessons from oligodendroglioma.
    Cairncross JG; Eisenhauer EA
    J Clin Oncol; 1995 Sep; 13(9):2475-6. PubMed ID: 7666112
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudo-subarachnoid hemorrhage and cortical visual impairment as the presenting sign of gliomatosis cerebri.
    Belsare G; Lee AG; Maley J; Kirby P; St Louis EK; Follett K
    Semin Ophthalmol; 2004; 19(3-4):78-80. PubMed ID: 15590541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
    Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCV chemotherapy for recurrent glioblastoma multiforme.
    Boiardi A
    Neurology; 2001 Jun; 56(12):1782. PubMed ID: 11425963
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
    Cairncross G; Macdonald D; Ludwin S; Lee D; Cascino T; Buckner J; Fulton D; Dropcho E; Stewart D; Schold C
    J Clin Oncol; 1994 Oct; 12(10):2013-21. PubMed ID: 7931469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliomatosis cerebri.
    Gleizniene R; Bucinskas U; Lukosevicius S; Vaitkus A; Letautiene S; Apanaviciūte D; Galvonaite M
    Medicina (Kaunas); 2010; 46(5):341-4. PubMed ID: 20679750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.